User: Guest  Login
Title:

Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication

Document type:
Journal Article
Author(s):
Nganou-Makamdop, K.; Billingsley, J. M.; Yaffe, Z.; O'Connor, G.; Tharp, G. K.; Ransier, A.; Laboune, F.; Matus-Nicodemos, R.; Lerner, A.; Gharu, L.; Robertson, J. M.; Ford, M. L.; Schlapschy, M.; Kuhn, N.; Lensch, A.; Lifson, J.; Nason, M.; Skerra, A.; Schreiber, G.; Bosinger, S. E.; Douek, D. C.
Journal title:
PLoS Pathog
Year:
2018
Journal volume:
14
Journal issue:
8
Pages contribution:
e1007246
Fulltext / DOI:
doi:10.1371/journal.ppat.1007246
WWW:
https://www.ncbi.nlm.nih.gov/pubmed/30142226
Print-ISSN:
1553-7374 (Electronic) 1553-7366 (Linking)
 BibTeX